Objective: To identify children with ADHD enrolled in New York State (NYS) Medicaid and characterize ADHD-associated costs by treatment category. Method: In 2013, 1.4 million children aged 2 to 17 years were enrolled in NYS Medicaid. Medicaid claims and encounters were used to identify children with ADHD, classify them by type of treatment received, and estimate associated costs. Results: The ADHD cohort comprised 5.4% of all Medicaid-enrolled children, with 35.0% receiving medication only, 16.2% receiving psychological services only, 42.2% receiving both, and 6.6% receiving neither. The total costs for the ADHD cohort (US$729.3 million) accounted for 18.1% of the total costs for children enrolled in NYS Medicaid. Conclusion: This study underscores the importance of achieving a better understanding of children with ADHD enrolled in NYS Medicaid. A framework to categorize children with ADHD based on their treatment categories may help to target interventions to improve the quality of care and reduce costs.
Objective: To identify children with ADHD enrolled in New York State (NYS) Medicaid and characterize ADHD-associated costs by treatment category. Method: In 2013, 1.4 million children aged 2 to 17 years were enrolled in NYS Medicaid. Medicaid claims and encounters were used to identify children with ADHD, classify them by type of treatment received, and estimate associated costs. Results: The ADHD cohort comprised 5.4% of all Medicaid-enrolled children, with 35.0% receiving medication only, 16.2% receiving psychological services only, 42.2% receiving both, and 6.6% receiving neither. The total costs for the ADHD cohort (US$729.3 million) accounted for 18.1% of the total costs for children enrolled in NYS Medicaid. Conclusion: This study underscores the importance of achieving a better understanding of children with ADHD enrolled in NYS Medicaid. A framework to categorize children with ADHD based on their treatment categories may help to target interventions to improve the quality of care and reduce costs.
Authors: Melissa L Danielson; Rebecca H Bitsko; Reem M Ghandour; Joseph R Holbrook; Michael D Kogan; Stephen J Blumberg Journal: J Clin Child Adolesc Psychol Date: 2018-01-24
Authors: Anthony L Bui; Joseph L Dieleman; Hannah Hamavid; Maxwell Birger; Abigail Chapin; Herbert C Duber; Cody Horst; Alex Reynolds; Ellen Squires; Paul J Chung; Christopher J L Murray Journal: JAMA Pediatr Date: 2017-02-01 Impact factor: 16.193
Authors: Timothy F Page; William E Pelham; Gregory A Fabiano; Andrew R Greiner; Elizabeth M Gnagy; Katie C Hart; Stefany Coxe; James G Waxmonsky; E Michael Foster; William E Pelham Journal: J Clin Child Adolesc Psychol Date: 2016-01-25
Authors: William J Barbaresi; Robert C Colligan; Amy L Weaver; Robert G Voigt; Jill M Killian; Slavica K Katusic Journal: Pediatrics Date: 2013-03-04 Impact factor: 7.124
Authors: J Koerting; E Smith; M M Knowles; S Latter; H Elsey; D C McCann; M Thompson; E J Sonuga-Barke Journal: Eur Child Adolesc Psychiatry Date: 2013-04-06 Impact factor: 4.785
Authors: Yu Shi; Lindsay R Hunter Guevara; Hayley J Dykhoff; Lindsey R Sangaralingham; Sean Phelan; Michael J Zaccariello; David O Warner Journal: JAMA Netw Open Date: 2021-03-01